» Articles » PMID: 38566911

Novel Erectile Analyses Revealed Augmentable Penile Lyve-1, the Lymphatic Marker, Expression

Overview
Journal Reprod Med Biol
Specialty Biology
Date 2024 Apr 3
PMID 38566911
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The pathophysiology of penis extends to erectile dysfunction (ED) to conditions including sexually transmitted diseases (STDs) and cancer. To date, there has been little research evaluating vascular drainage from the penis. We aimed to evaluate penile blood flow in vivo and analyze its possible relationship with the lymphatic maker.

Materials And Methods: We established an in vivo system designed to assess the dynamic blood outflow from the corpus cavernosum (CC) by dye injection. To analyze lymphatic characteristics in the CC, the expression of Lyve-1, the key lymphatic endothelium marker, was examined by the in vitro system and lipopolysaccharide (LPS) injection to mimic the inflammatory conditions.

Results: A novel cavernography methods enable high-resolution morphological and functional blood drainage analysis. The expression of Lyve-1 was detected along the sinusoids. Furthermore, its prominent expression was also observed after penile LPS injection and in the erectile condition.

Conclusions: The current in vivo system will potentially contribute to the assessment of penile pathology from a novel viewpoint. In addition, current analyses revealed inducible Lyve-1 expression for LPS injection and the erection state, which requires further analyses on penile lymphatic system.

Citing Articles

Developmental and functional roles of androgen and interactive signals for external genitalia and erectile tissues.

Hashimoto D, Fujimoto K, Nakata M, Suzuki T, Kumegawa S, Ueda Y Reprod Med Biol. 2024; 23(1):e12611.

PMID: 39372370 PMC: 11456227. DOI: 10.1002/rmb2.12611.


Novel erectile analyses revealed augmentable penile Lyve-1, the lymphatic marker, expression.

Fujimoto K, Hashimoto D, Kim S, Lee Y, Suzuki T, Nakata M Reprod Med Biol. 2024; 23(1):e12570.

PMID: 38566911 PMC: 10985380. DOI: 10.1002/rmb2.12570.

References
1.
Feldman H, Goldstein I, Hatzichristou D, Krane R, McKinlay J . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994; 151(1):54-61. DOI: 10.1016/s0022-5347(17)34871-1. View

2.
Jena A, Goldman D, Kamdar A, Lakdawalla D, Lu Y . Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med. 2010; 153(1):1-7. PMC: 3673772. DOI: 10.7326/0003-4819-153-1-201007060-00003. View

3.
Bayraktar N . Non-invasive alternative for phosphodiesterase inhibitor-refractory erectile dysfunction: Real-life experience with low-intensity extracorporeal shockwave therapy. Medicine (Baltimore). 2023; 102(45):e35939. PMC: 10637505. DOI: 10.1097/MD.0000000000035939. View

4.
Suh C, Baheti A, Tirumani S, Rosenthal M, Kim K, Ramaiya N . Multimodality imaging of penile cancer: what radiologists need to know. Abdom Imaging. 2014; 40(2):424-35. DOI: 10.1007/s00261-014-0218-6. View

5.
Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K . Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999; 154(2):385-94. PMC: 1849992. DOI: 10.1016/S0002-9440(10)65285-6. View